Antimicrobial Agents and Chemotherapy · 2008 · 48 citations · 48 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyMolecular PharmacologyPharmacodynamicsAntiretroviral TherapyAntiviral AgentsAntiviral PharmacotherapyAntiviral TherapyCellular Drug EffluxPharmacokinetic Drug InteractionsAbc Transporter InvolvementAntiretroviral InteractionsDrug Efflux MechanismsEfflux Transporter ModulationHiv Antiretroviral TherapyMultidrug Resistance-associated Protein-mediated EffluxOrganic Anion Transporter InteractionsPharmacokinetics Of Antiretroviral Drugs
Efflux proteins have been shown to greatly affect the uptake of antiretroviral drugs by cells and to hamper their access to the human immunodeficiency virus type 1 replication site. This study evaluated the factors that may lead to drug-drug interactions between emtricitabine (FTC), tenofovir (TFV), and efavirenz (EFV), including the modulation of efflux transporter expression and function. Peripheral blood mononuclear cells from healthy volunteers were used to determine whether or not an interaction between antiretroviral drugs and target cells occurred in any combination of FTC, TFV, EFV, FTC-TFV, TFV-EFV, or FTC-TFV-EFV. Following 20 h of treatment, intracellular drug concentrations were measured by liquid chromatography-tandem mass spectrometry. Efflux transporter functionality and inhibitor drug properties were assessed by measuring fluorescent dye efflux. ABCB1 (P-glycoprotein), ABCC 1 to 6 (multidrug resistance-associated protein), and OAT (organic anion transporter) expression in response to the treatments was quantified by semiquantitative real-time PCR. Cells treated with a double combination (FTC-TFV or TFV-EFV) or the triple combination (FTC-TFV-EFV) produced higher FTC and TFV intracellular concentrations than cells treated with FTC or TFV alone. However, no change in the EFV intracellular concentration was observed. FTC tended to induce abcc5 mRNA expression and EFV tended to induce abcc1 and abcc6 mRNA expression, whereas TFV tended to reduce mdr1, abcc1, abcc5, and abcc6 mRNA expression. Under these conditions, a decrease in the functionality of ABCC was observed, and this decrease was associated with the direct inhibitory actions of these drugs. This in vitro study reveals a benefit of the combination FTC-TFV-EFV in terms of the intracellular FTC and TFV concentrations and highlights the pharmacological mechanisms that lead to this effect.
48
Treatment for Adult HIV Infection
Scott M. Hammer, Michael S. Saag, Mauro Schechter et al. · JAMA · 2006 · 1K citations
Heidi R. Kast-Woelbern, Bryan Goodwin, Paul T. Tarr et al. · Journal of Biological Chemistry · 2002 · 908 citations · Full text
Treatment for Adult HIV Infection
Patrick Yéni, Scott M. Hammer, Martin Hirsch et al. · JAMA · 2004 · 737 citations
HIV-1 Protease Inhibitors Are Substrates for the<i>MDR</i>1 Multidrug Transporter
Caroline Lee, Michael M. Gottesman, Carol Cardarelli et al. · Biochemistry · 1998 · 482 citations